Valuation: ResMed, Inc.

Market Cap 3.56TCr 3.18TCr 2.94TCr 2.66TCr 4.97TCr 3,38600Cr 5.05TCr 35TCr 14TCr 1,77200Cr 13TCr 13TCr 5,61300Cr P/E 2027 *
21.7x
P/E 2028 * 19.7x
Enterprise Value 3.46TCr 3.1TCr 2.86TCr 2.58TCr 4.83TCr 3,29100Cr 4.91TCr 34TCr 14TCr 1,72200Cr 13TCr 13TCr 5,45500Cr EV / Sales 2027 *
5.95x
EV / Sales 2028 * 5.5x
Free-Float
74.65%
Yield 2027 *
1.06%
Yield 2028 * 1.15%
1 day+1.06%
1 week-0.09%
Current month+14.35%
1 month+13.46%
3 months+17.98%
6 months+19.30%
Current year+4.97%
1 week 247.7
Extreme 247.7
254.99
1 month 218.03
Extreme 218.03
255.56
Current year 180.26
Extreme 180.265
277.67
1 year 180.26
Extreme 180.265
277.67
3 years 138.55
Extreme 138.55
293.81
5 years 132.24
Extreme 132.24
293.81
10 years 56.59
Extreme 56.59
301.34
Manager TitleAgeSince
Chief Executive Officer 54 01/03/2013
Director of Finance/CFO 41 04/05/2026
Chief Tech/Sci/R&D Officer - 01/02/2024
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 54 25/01/2023
Chairman 84 01/06/1989
Date Insider Type Main position Quantity % Market Cap. Importance
07/10/26 Exercice

Chief Executive Officer

14,973 0.0104%
08/09/26 Exercice

Chief Executive Officer

14,973 0.0104%
08/09/26 Other

Chief Executive Officer

0 0%
Change 5-day change 1-year change 3-year change Capi.($)
+1.06%-0.09%-0.31%+87.77% 3.52TCr
+0.71%+4.82%+27.02%+64.39% 26TCr
+1.24%+3.15%+10.73%+26.13% 16TCr
+1.03%+1.11%-16.52%+73.28% 15TCr
+0.61%-7.22%-57.44%-13.79% 6.15TCr
+2.90%+4.83%+14.21%+53.04% 5.29TCr
+0.70%+2.71%-13.09%-6.48% 5.28TCr
-2.35%-3.79%+8.26%+63.75% 5.15TCr
-0.18%+4.18%+26.50%+76.27% 5.12TCr
+0.67%+5.37%+39.77%+96.14% 4.69TCr
Average +0.64%+1.51%+3.91%+52.05% 9.31TCr
Weighted average by Cap. +0.77%+2.33%+6.90%+52.36%

Financials

2027 *2028 *
Net sales 580.28Cr 519.76Cr 479.51Cr 433.92Cr 811.41Cr 55TCr 824.53Cr 5.72TCr 2.28TCr 29TCr 2.18TCr 2.13TCr 92TCr 617.81Cr 553.37Cr 510.52Cr 461.99Cr 863.89Cr 59TCr 877.85Cr 6.09TCr 2.43TCr 31TCr 2.32TCr 2.27TCr 98TCr
Net income 164.04Cr 146.93Cr 135.56Cr 122.67Cr 229.38Cr 16TCr 233.09Cr 1.62TCr 645.19Cr 8.18TCr 615.64Cr 602.54Cr 26TCr 178.14Cr 159.56Cr 147.2Cr 133.21Cr 249.09Cr 17TCr 253.11Cr 1.76TCr 700.61Cr 8.88TCr 668.53Cr 654.29Cr 28TCr
Net Debt -100.21Cr -90Cr -83Cr -75Cr -140.12Cr -9.54TCr -142.39Cr -987.91Cr -394.12Cr -4.99TCr -376.07Cr -368.06Cr -16TCr -155.56Cr -139.34Cr -128.55Cr -116.33Cr -217.52Cr -15TCr -221.04Cr -1.53TCr -611.83Cr -7.75TCr -583.81Cr -571.38Cr -25TCr
Projected Income Statement - Annual - ResMed, Inc.
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.2%); - masks (36.9%); - software as a service (11.9%): residential care management software solutions. At the end of June 2026, the group had 9 production sites located in the United States (4), Australia, China, Singapore, Malaysia and France. The United States accounts for 63% of net sales.
Employees
11,370
Date Price Change Volume
29/26/29 $252.83 +1.06% 14,50,972
28/26/28 $250.17 -0.25% 10,20,371
27/26/27 $250.80 -0.95% 9,36,664
26/26/26 $253.20 +0.13% 10,74,677
23/26/23 $252.86 -0.08% 10,32,414
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - ResMed, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
252.83USD
Average target price
251.52USD
Spread / Average Target
-0.52%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - ResMed, Inc.